Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA416287
Max Phase: Preclinical
Molecular Formula: C41H53N13O13
Molecular Weight: 935.95
Molecule Type: Protein
Associated Items:
ID: ALA416287
Max Phase: Preclinical
Molecular Formula: C41H53N13O13
Molecular Weight: 935.95
Molecule Type: Protein
Associated Items:
Canonical SMILES: C[C@@H]1NC(=O)[C@@H]([C@@H](C)O)NC(=O)CNC(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CC(N)=O)NC(=O)CNC(=O)C[C@H](C(=O)O)NC(=O)[C@H]2CCCN2C1=O
Standard InChI: InChI=1S/C41H53N13O13/c1-19-40(65)54-9-5-8-29(54)38(63)52-28(41(66)67)13-31(57)45-16-32(58)49-27(12-30(42)56)37(62)50-25(10-21-14-44-24-7-4-3-6-23(21)24)36(61)51-26(11-22-15-43-18-47-22)35(60)46-17-33(59)53-34(20(2)55)39(64)48-19/h3-4,6-7,14-15,18-20,25-29,34,44,55H,5,8-13,16-17H2,1-2H3,(H2,42,56)(H,43,47)(H,45,57)(H,46,60)(H,48,64)(H,49,58)(H,50,62)(H,51,61)(H,52,63)(H,53,59)(H,66,67)/t19-,20+,25-,26+,27+,28+,29+,34+/m0/s1
Standard InChI Key: KSMDTXOOAPSTEL-HFYOPZJCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 935.95 | Molecular Weight (Monoisotopic): 935.3886 | AlogP: -5.43 | #Rotatable Bonds: 8 |
Polar Surface Area: 398.20 | Molecular Species: ACID | HBA: 13 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 26 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.63 | CX Basic pKa: 6.53 | CX LogP: -8.37 | CX LogD: -9.27 |
Aromatic Rings: 3 | Heavy Atoms: 67 | QED Weighted: 0.10 | Np Likeness Score: 0.98 |
1. Suzawa T, Shibata K, Tanaka T, Matsuda Y, Yamasaki M. (1997) RES-701-1/endothelin-1 hybrid peptide having a potent binding activity for type B receptor, 7 (13): [10.1016/S0960-894X(97)00296-5] |
Source(1):